4933426I21Rik Activators encompass a range of chemical compounds that indirectly increase the functional activity of the protein 4933426I21Rik through various signaling mechanisms. Forskolin, through the elevation of cAMP, indirectly fosters 4933426I21Rik's function by triggering PKA, which then phosphorylates proteins in pathways that engage 4933426I21Rik, thereby promoting its activity. Similarly, PMA, as a PKC activator, can phosphorylate proteins within the same cascade, enhancing the protein's function. Ionomycin and A23187, by raising intracellular calcium levels, activate calcium-dependent pathways that can interface with 4933426I21Rik, potentially intensifying its activity. Compounds like 8-Bromo-cAMP andIsoproterenol directly boost PKA signaling, which may subsequently lead to the phosphorylation of substrates within the 4933426I21Rik pathway, thus indirectly augmenting the protein's functional activity. Epigallocatechin gallate (EGCG) and Genistein, through their inhibitory effects on certain kinases, might reduce competitive inhibitory phosphorylation, indirectly facilitating the enhancement of 4933426I21Rik-related pathways. Additionally, LY294002 and U0126, by modulating PI3K and MEK1/2 respectively, might also shift signaling dynamics to favor the activation of pathways in which 4933426I21Rik participates.
The sphingosine-1-phosphate and thapsigargin both play roles in manipulating the intracellular milieu to favor the activation of 4933426I21Rik. Sphingosine-1-phosphate does this by engaging its receptors and initiating a downstream signaling cascade that intersects with 4933426I21Rik's pathway, thereby indirectly bolstering its function. On the other hand, thapsigargin, by impeding the SERCA pump and consequently upping cytosolic calcium levels, might trigger calcium-dependent signaling pathways that could lead to the enhanced activity of 4933426I21Rik. Collectively, these activators function through diverse but interconnected signaling pathways, each contributing to the amplification of 4933426I21Rik's activity in the cell without directly upregulating its expression or acting as direct ligands to the protein itself.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA is a diacylglycerol analog which activates protein kinase C (PKC). PKC activation can lead to phosphorylation of proteins within the signaling cascade that 4933426I21Rik is a part of, thereby enhancing the functional activity of 4933426I21Rik. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore that increases intracellular calcium levels, potentially activating calcium-dependent signaling pathways and proteins that interact with 4933426I21Rik, indirectly enhancing its activity. | ||||||
8-Bromoadenosine 3′,5′-cyclic monophosphate | 23583-48-4 | sc-217493B sc-217493 sc-217493A sc-217493C sc-217493D | 25 mg 50 mg 100 mg 250 mg 500 mg | $108.00 $169.00 $295.00 $561.00 $835.00 | 2 | |
8-Bromo-cAMP is a cell-permeable cAMP analog that activates PKA. PKA can then phosphorylate substrates that may interact with or modulate the activity of 4933426I21Rik, thereby indirectly enhancing its function. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG is a polyphenol that can inhibit certain kinases, potentially reducing inhibitory phosphorylation of proteins within the pathway of 4933426I21Rik and thus indirectly increasing the activity of 4933426I21Rik. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A23187 is an ionophore that facilitates the influx of calcium, activating calcium-dependent signaling pathways. These pathways could include proteins that are part of the signaling network of 4933426I21Rik, thereby enhancing its activity. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor that may lead to alterations in downstream signaling pathways, potentially relieving inhibitory control over proteins that interact with or regulate 4933426I21Rik, enhancing its activity. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $165.00 $322.00 $570.00 $907.00 $1727.00 | 7 | |
Sphingosine-1-phosphate activates sphingosine-1-phosphate receptors, which can lead to cascades that result in the activation of signaling pathways involving 4933426I21Rik, thus enhancing its function. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
Genistein is a tyrosine kinase inhibitor that could diminish competitive pathways and thereby indirectly enhance the signal transduction pathways that involve 4933426I21Rik. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Thapsigargin is a SERCA pump inhibitor that leads to an increase in cytosolic calcium levels, potentially activating calcium-dependent proteins and signaling pathways that include 4933426I21Rik, enhancing its activity. | ||||||